nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.039	0.0517	CbGbCtD
Cyclophosphamide—CYP3A7—Simvastatin—atherosclerosis	0.039	0.0517	CbGbCtD
Cyclophosphamide—CYP3A7—Lovastatin—atherosclerosis	0.0382	0.0506	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0382	0.0506	CbGbCtD
Cyclophosphamide—CYP2B6—Simvastatin—atherosclerosis	0.0372	0.0492	CbGbCtD
Cyclophosphamide—CYP3A5—Rosuvastatin—atherosclerosis	0.0315	0.0417	CbGbCtD
Cyclophosphamide—CYP3A5—Simvastatin—atherosclerosis	0.0293	0.0388	CbGbCtD
Cyclophosphamide—CYP3A5—Lovastatin—atherosclerosis	0.0287	0.0379	CbGbCtD
Cyclophosphamide—CYP3A5—Pravastatin—atherosclerosis	0.0287	0.0379	CbGbCtD
Cyclophosphamide—CYP2C8—Simvastatin—atherosclerosis	0.0282	0.0373	CbGbCtD
Cyclophosphamide—CYP2C8—Pravastatin—atherosclerosis	0.0276	0.0365	CbGbCtD
Cyclophosphamide—CYP2C8—Lovastatin—atherosclerosis	0.0276	0.0365	CbGbCtD
Cyclophosphamide—CYP2C19—Rosuvastatin—atherosclerosis	0.0254	0.0336	CbGbCtD
Cyclophosphamide—CYP2C19—Simvastatin—atherosclerosis	0.0236	0.0313	CbGbCtD
Cyclophosphamide—CYP2C19—Lovastatin—atherosclerosis	0.0231	0.0306	CbGbCtD
Cyclophosphamide—CYP2D6—Niacin—atherosclerosis	0.0227	0.0301	CbGbCtD
Cyclophosphamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0211	0.028	CbGbCtD
Cyclophosphamide—ABCB1—Ezetimibe—atherosclerosis	0.0205	0.0271	CbGbCtD
Cyclophosphamide—CYP2C9—Simvastatin—atherosclerosis	0.0196	0.026	CbGbCtD
Cyclophosphamide—CYP2C9—Pravastatin—atherosclerosis	0.0192	0.0254	CbGbCtD
Cyclophosphamide—CYP2C9—Lovastatin—atherosclerosis	0.0192	0.0254	CbGbCtD
Cyclophosphamide—ABCB1—Simvastatin—atherosclerosis	0.0191	0.0252	CbGbCtD
Cyclophosphamide—ABCB1—Pravastatin—atherosclerosis	0.0186	0.0247	CbGbCtD
Cyclophosphamide—ABCB1—Lovastatin—atherosclerosis	0.0186	0.0247	CbGbCtD
Cyclophosphamide—CYP2D6—Simvastatin—atherosclerosis	0.018	0.0238	CbGbCtD
Cyclophosphamide—CYP2D6—Lovastatin—atherosclerosis	0.0176	0.0233	CbGbCtD
Cyclophosphamide—CYP2D6—Pravastatin—atherosclerosis	0.0176	0.0233	CbGbCtD
Cyclophosphamide—CYP3A4—Ezetimibe—atherosclerosis	0.0123	0.0163	CbGbCtD
Cyclophosphamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0123	0.0163	CbGbCtD
Cyclophosphamide—CYP3A4—Simvastatin—atherosclerosis	0.0114	0.0151	CbGbCtD
Cyclophosphamide—CYP3A4—Pravastatin—atherosclerosis	0.0112	0.0148	CbGbCtD
Cyclophosphamide—CYP3A4—Lovastatin—atherosclerosis	0.0112	0.0148	CbGbCtD
Cyclophosphamide—Jaundice—Simvastatin—atherosclerosis	0.000425	0.00226	CcSEcCtD
Cyclophosphamide—Hepatitis—Lovastatin—atherosclerosis	0.000419	0.00222	CcSEcCtD
Cyclophosphamide—Hepatitis—Ezetimibe—atherosclerosis	0.000411	0.00218	CcSEcCtD
Cyclophosphamide—Weight increased—Pravastatin—atherosclerosis	0.000402	0.00214	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Lovastatin—atherosclerosis	0.000396	0.0021	CcSEcCtD
Cyclophosphamide—Hepatitis—Simvastatin—atherosclerosis	0.000391	0.00208	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000391	0.00208	CcSEcCtD
Cyclophosphamide—Jaundice—Niacin—atherosclerosis	0.00039	0.00207	CcSEcCtD
Cyclophosphamide—Stomatitis—Niacin—atherosclerosis	0.00039	0.00207	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000389	0.00206	CcSEcCtD
Cyclophosphamide—Flushing—Lovastatin—atherosclerosis	0.000388	0.00206	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000388	0.00206	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000386	0.00205	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Pravastatin—atherosclerosis	0.000386	0.00205	CcSEcCtD
Cyclophosphamide—Jaundice—Pravastatin—atherosclerosis	0.000384	0.00204	CcSEcCtD
Cyclophosphamide—Sweating—Niacin—atherosclerosis	0.000384	0.00204	CcSEcCtD
Cyclophosphamide—Flushing—Ezetimibe—atherosclerosis	0.000381	0.00202	CcSEcCtD
Cyclophosphamide—Chills—Lovastatin—atherosclerosis	0.000376	0.00199	CcSEcCtD
Cyclophosphamide—Cough—Rosuvastatin—atherosclerosis	0.000375	0.00199	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Simvastatin—atherosclerosis	0.00037	0.00197	CcSEcCtD
Cyclophosphamide—Alopecia—Lovastatin—atherosclerosis	0.00037	0.00196	CcSEcCtD
Cyclophosphamide—Myalgia—Rosuvastatin—atherosclerosis	0.000366	0.00194	CcSEcCtD
Cyclophosphamide—Arthralgia—Rosuvastatin—atherosclerosis	0.000366	0.00194	CcSEcCtD
Cyclophosphamide—Flushing—Simvastatin—atherosclerosis	0.000363	0.00193	CcSEcCtD
Cyclophosphamide—Alopecia—Ezetimibe—atherosclerosis	0.000363	0.00193	CcSEcCtD
Cyclophosphamide—Haemoglobin—Niacin—atherosclerosis	0.000361	0.00192	CcSEcCtD
Cyclophosphamide—Rhinitis—Niacin—atherosclerosis	0.00036	0.00191	CcSEcCtD
Cyclophosphamide—Haemorrhage—Niacin—atherosclerosis	0.000359	0.00191	CcSEcCtD
Cyclophosphamide—Hepatitis—Niacin—atherosclerosis	0.000359	0.00191	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Niacin—atherosclerosis	0.000358	0.0019	CcSEcCtD
Cyclophosphamide—Erythema—Ezetimibe—atherosclerosis	0.000357	0.0019	CcSEcCtD
Cyclophosphamide—Dysgeusia—Lovastatin—atherosclerosis	0.000357	0.00189	CcSEcCtD
Cyclophosphamide—Rhinitis—Pravastatin—atherosclerosis	0.000355	0.00188	CcSEcCtD
Cyclophosphamide—Hepatitis—Pravastatin—atherosclerosis	0.000354	0.00188	CcSEcCtD
Cyclophosphamide—Confusional state—Rosuvastatin—atherosclerosis	0.000354	0.00188	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Pravastatin—atherosclerosis	0.000352	0.00187	CcSEcCtD
Cyclophosphamide—Chills—Simvastatin—atherosclerosis	0.000351	0.00186	CcSEcCtD
Cyclophosphamide—Muscle spasms—Lovastatin—atherosclerosis	0.00035	0.00186	CcSEcCtD
Cyclophosphamide—Infection—Rosuvastatin—atherosclerosis	0.000349	0.00185	CcSEcCtD
Cyclophosphamide—Visual impairment—Niacin—atherosclerosis	0.000346	0.00184	CcSEcCtD
Cyclophosphamide—Alopecia—Simvastatin—atherosclerosis	0.000346	0.00184	CcSEcCtD
Cyclophosphamide—Muscle spasms—Ezetimibe—atherosclerosis	0.000344	0.00182	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000344	0.00182	CcSEcCtD
Cyclophosphamide—Vision blurred—Lovastatin—atherosclerosis	0.000343	0.00182	CcSEcCtD
Cyclophosphamide—Tremor—Lovastatin—atherosclerosis	0.000341	0.00181	CcSEcCtD
Cyclophosphamide—Visual impairment—Pravastatin—atherosclerosis	0.000341	0.00181	CcSEcCtD
Cyclophosphamide—Erythema—Simvastatin—atherosclerosis	0.000341	0.00181	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000338	0.00179	CcSEcCtD
Cyclophosphamide—Tinnitus—Niacin—atherosclerosis	0.000335	0.00178	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Pravastatin—atherosclerosis	0.000335	0.00178	CcSEcCtD
Cyclophosphamide—Dysgeusia—Simvastatin—atherosclerosis	0.000334	0.00177	CcSEcCtD
Cyclophosphamide—Flushing—Niacin—atherosclerosis	0.000334	0.00177	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000332	0.00176	CcSEcCtD
Cyclophosphamide—Anaemia—Ezetimibe—atherosclerosis	0.00033	0.00175	CcSEcCtD
Cyclophosphamide—Tinnitus—Pravastatin—atherosclerosis	0.00033	0.00175	CcSEcCtD
Cyclophosphamide—Malaise—Lovastatin—atherosclerosis	0.000329	0.00174	CcSEcCtD
Cyclophosphamide—Flushing—Pravastatin—atherosclerosis	0.000328	0.00174	CcSEcCtD
Cyclophosphamide—Muscle spasms—Simvastatin—atherosclerosis	0.000328	0.00174	CcSEcCtD
Cyclophosphamide—Leukopenia—Lovastatin—atherosclerosis	0.000326	0.00173	CcSEcCtD
Cyclophosphamide—Chills—Niacin—atherosclerosis	0.000323	0.00171	CcSEcCtD
Cyclophosphamide—Malaise—Ezetimibe—atherosclerosis	0.000322	0.00171	CcSEcCtD
Cyclophosphamide—Vision blurred—Simvastatin—atherosclerosis	0.000321	0.00171	CcSEcCtD
Cyclophosphamide—Arrhythmia—Niacin—atherosclerosis	0.000321	0.0017	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00032	0.0017	CcSEcCtD
Cyclophosphamide—Tremor—Simvastatin—atherosclerosis	0.000319	0.0017	CcSEcCtD
Cyclophosphamide—Alopecia—Niacin—atherosclerosis	0.000318	0.00169	CcSEcCtD
Cyclophosphamide—Chills—Pravastatin—atherosclerosis	0.000318	0.00169	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000316	0.00168	CcSEcCtD
Cyclophosphamide—Arrhythmia—Pravastatin—atherosclerosis	0.000316	0.00168	CcSEcCtD
Cyclophosphamide—Palpitations—Ezetimibe—atherosclerosis	0.000316	0.00168	CcSEcCtD
Cyclophosphamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000315	0.00167	CcSEcCtD
Cyclophosphamide—Anaemia—Simvastatin—atherosclerosis	0.000315	0.00167	CcSEcCtD
Cyclophosphamide—Erythema—Niacin—atherosclerosis	0.000313	0.00166	CcSEcCtD
Cyclophosphamide—Alopecia—Pravastatin—atherosclerosis	0.000313	0.00166	CcSEcCtD
Cyclophosphamide—Cough—Ezetimibe—atherosclerosis	0.000312	0.00166	CcSEcCtD
Cyclophosphamide—Chest pain—Lovastatin—atherosclerosis	0.00031	0.00165	CcSEcCtD
Cyclophosphamide—Arthralgia—Lovastatin—atherosclerosis	0.00031	0.00165	CcSEcCtD
Cyclophosphamide—Myalgia—Lovastatin—atherosclerosis	0.00031	0.00165	CcSEcCtD
Cyclophosphamide—Hypertension—Ezetimibe—atherosclerosis	0.000309	0.00164	CcSEcCtD
Cyclophosphamide—Malaise—Simvastatin—atherosclerosis	0.000307	0.00163	CcSEcCtD
Cyclophosphamide—Discomfort—Lovastatin—atherosclerosis	0.000306	0.00163	CcSEcCtD
Cyclophosphamide—Leukopenia—Simvastatin—atherosclerosis	0.000305	0.00162	CcSEcCtD
Cyclophosphamide—Myalgia—Ezetimibe—atherosclerosis	0.000304	0.00162	CcSEcCtD
Cyclophosphamide—Arthralgia—Ezetimibe—atherosclerosis	0.000304	0.00162	CcSEcCtD
Cyclophosphamide—Chest pain—Ezetimibe—atherosclerosis	0.000304	0.00162	CcSEcCtD
Cyclophosphamide—Dysgeusia—Pravastatin—atherosclerosis	0.000302	0.0016	CcSEcCtD
Cyclophosphamide—Muscle spasms—Niacin—atherosclerosis	0.000301	0.0016	CcSEcCtD
Cyclophosphamide—Discomfort—Ezetimibe—atherosclerosis	0.000301	0.0016	CcSEcCtD
Cyclophosphamide—Pain—Rosuvastatin—atherosclerosis	0.0003	0.00159	CcSEcCtD
Cyclophosphamide—Constipation—Rosuvastatin—atherosclerosis	0.0003	0.00159	CcSEcCtD
Cyclophosphamide—Confusional state—Lovastatin—atherosclerosis	0.0003	0.00159	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000297	0.00158	CcSEcCtD
Cyclophosphamide—Muscle spasms—Pravastatin—atherosclerosis	0.000296	0.00157	CcSEcCtD
Cyclophosphamide—Infection—Lovastatin—atherosclerosis	0.000295	0.00157	CcSEcCtD
Cyclophosphamide—Vision blurred—Niacin—atherosclerosis	0.000295	0.00157	CcSEcCtD
Cyclophosphamide—Confusional state—Ezetimibe—atherosclerosis	0.000294	0.00156	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000292	0.00155	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000291	0.00155	CcSEcCtD
Cyclophosphamide—Vision blurred—Pravastatin—atherosclerosis	0.00029	0.00154	CcSEcCtD
Cyclophosphamide—Chest pain—Simvastatin—atherosclerosis	0.00029	0.00154	CcSEcCtD
Cyclophosphamide—Arthralgia—Simvastatin—atherosclerosis	0.00029	0.00154	CcSEcCtD
Cyclophosphamide—Myalgia—Simvastatin—atherosclerosis	0.00029	0.00154	CcSEcCtD
Cyclophosphamide—Infection—Ezetimibe—atherosclerosis	0.00029	0.00154	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000289	0.00154	CcSEcCtD
Cyclophosphamide—Tremor—Pravastatin—atherosclerosis	0.000289	0.00153	CcSEcCtD
Cyclophosphamide—Discomfort—Simvastatin—atherosclerosis	0.000287	0.00152	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000286	0.00152	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000286	0.00152	CcSEcCtD
Cyclophosphamide—Anaemia—Pravastatin—atherosclerosis	0.000285	0.00151	CcSEcCtD
Cyclophosphamide—Anorexia—Lovastatin—atherosclerosis	0.000283	0.0015	CcSEcCtD
Cyclophosphamide—Confusional state—Simvastatin—atherosclerosis	0.00028	0.00149	CcSEcCtD
Cyclophosphamide—Leukopenia—Niacin—atherosclerosis	0.00028	0.00149	CcSEcCtD
Cyclophosphamide—Urticaria—Rosuvastatin—atherosclerosis	0.000279	0.00148	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000278	0.00148	CcSEcCtD
Cyclophosphamide—Oedema—Simvastatin—atherosclerosis	0.000278	0.00148	CcSEcCtD
Cyclophosphamide—Malaise—Pravastatin—atherosclerosis	0.000278	0.00148	CcSEcCtD
Cyclophosphamide—Palpitations—Niacin—atherosclerosis	0.000277	0.00147	CcSEcCtD
Cyclophosphamide—Infection—Simvastatin—atherosclerosis	0.000276	0.00147	CcSEcCtD
Cyclophosphamide—Leukopenia—Pravastatin—atherosclerosis	0.000276	0.00146	CcSEcCtD
Cyclophosphamide—Cough—Niacin—atherosclerosis	0.000273	0.00145	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000272	0.00145	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000271	0.00144	CcSEcCtD
Cyclophosphamide—Cough—Pravastatin—atherosclerosis	0.000269	0.00143	CcSEcCtD
Cyclophosphamide—Paraesthesia—Lovastatin—atherosclerosis	0.000267	0.00142	CcSEcCtD
Cyclophosphamide—Myalgia—Niacin—atherosclerosis	0.000266	0.00141	CcSEcCtD
Cyclophosphamide—Arthralgia—Niacin—atherosclerosis	0.000266	0.00141	CcSEcCtD
Cyclophosphamide—Hypertension—Pravastatin—atherosclerosis	0.000266	0.00141	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000266	0.00141	CcSEcCtD
Cyclophosphamide—Anorexia—Simvastatin—atherosclerosis	0.000265	0.00141	CcSEcCtD
Cyclophosphamide—Dyspnoea—Lovastatin—atherosclerosis	0.000265	0.00141	CcSEcCtD
Cyclophosphamide—Chest pain—Pravastatin—atherosclerosis	0.000262	0.00139	CcSEcCtD
Cyclophosphamide—Myalgia—Pravastatin—atherosclerosis	0.000262	0.00139	CcSEcCtD
Cyclophosphamide—Arthralgia—Pravastatin—atherosclerosis	0.000262	0.00139	CcSEcCtD
Cyclophosphamide—Paraesthesia—Ezetimibe—atherosclerosis	0.000262	0.00139	CcSEcCtD
Cyclophosphamide—Dyspnoea—Ezetimibe—atherosclerosis	0.00026	0.00138	CcSEcCtD
Cyclophosphamide—Discomfort—Pravastatin—atherosclerosis	0.000259	0.00138	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000259	0.00137	CcSEcCtD
Cyclophosphamide—Decreased appetite—Lovastatin—atherosclerosis	0.000258	0.00137	CcSEcCtD
Cyclophosphamide—Fatigue—Lovastatin—atherosclerosis	0.000256	0.00136	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Niacin—atherosclerosis	0.000255	0.00136	CcSEcCtD
Cyclophosphamide—Oedema—Niacin—atherosclerosis	0.000255	0.00136	CcSEcCtD
Cyclophosphamide—Pain—Lovastatin—atherosclerosis	0.000254	0.00135	CcSEcCtD
Cyclophosphamide—Constipation—Lovastatin—atherosclerosis	0.000254	0.00135	CcSEcCtD
Cyclophosphamide—Confusional state—Pravastatin—atherosclerosis	0.000254	0.00135	CcSEcCtD
Cyclophosphamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000254	0.00135	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000253	0.00135	CcSEcCtD
Cyclophosphamide—Asthenia—Rosuvastatin—atherosclerosis	0.000252	0.00134	CcSEcCtD
Cyclophosphamide—Oedema—Pravastatin—atherosclerosis	0.000251	0.00133	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000251	0.00133	CcSEcCtD
Cyclophosphamide—Fatigue—Ezetimibe—atherosclerosis	0.000251	0.00133	CcSEcCtD
Cyclophosphamide—Shock—Niacin—atherosclerosis	0.000251	0.00133	CcSEcCtD
Cyclophosphamide—Infection—Pravastatin—atherosclerosis	0.00025	0.00133	CcSEcCtD
Cyclophosphamide—Paraesthesia—Simvastatin—atherosclerosis	0.00025	0.00133	CcSEcCtD
Cyclophosphamide—Pain—Ezetimibe—atherosclerosis	0.000249	0.00132	CcSEcCtD
Cyclophosphamide—Constipation—Ezetimibe—atherosclerosis	0.000249	0.00132	CcSEcCtD
Cyclophosphamide—Tachycardia—Niacin—atherosclerosis	0.000249	0.00132	CcSEcCtD
Cyclophosphamide—Pruritus—Rosuvastatin—atherosclerosis	0.000248	0.00132	CcSEcCtD
Cyclophosphamide—Dyspnoea—Simvastatin—atherosclerosis	0.000248	0.00132	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Niacin—atherosclerosis	0.000247	0.00131	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000246	0.00131	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Lovastatin—atherosclerosis	0.000245	0.0013	CcSEcCtD
Cyclophosphamide—Anorexia—Niacin—atherosclerosis	0.000243	0.00129	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000243	0.00129	CcSEcCtD
Cyclophosphamide—Decreased appetite—Simvastatin—atherosclerosis	0.000242	0.00128	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00024	0.00128	CcSEcCtD
Cyclophosphamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00024	0.00127	CcSEcCtD
Cyclophosphamide—Fatigue—Simvastatin—atherosclerosis	0.00024	0.00127	CcSEcCtD
Cyclophosphamide—Anorexia—Pravastatin—atherosclerosis	0.00024	0.00127	CcSEcCtD
Cyclophosphamide—Hypotension—Niacin—atherosclerosis	0.000239	0.00127	CcSEcCtD
Cyclophosphamide—Pain—Simvastatin—atherosclerosis	0.000238	0.00126	CcSEcCtD
Cyclophosphamide—Constipation—Simvastatin—atherosclerosis	0.000238	0.00126	CcSEcCtD
Cyclophosphamide—Urticaria—Lovastatin—atherosclerosis	0.000236	0.00125	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lovastatin—atherosclerosis	0.000235	0.00125	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000233	0.00124	CcSEcCtD
Cyclophosphamide—Dizziness—Rosuvastatin—atherosclerosis	0.000232	0.00123	CcSEcCtD
Cyclophosphamide—Urticaria—Ezetimibe—atherosclerosis	0.000232	0.00123	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ezetimibe—atherosclerosis	0.000231	0.00122	CcSEcCtD
Cyclophosphamide—Paraesthesia—Niacin—atherosclerosis	0.000229	0.00122	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000229	0.00122	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000229	0.00122	CcSEcCtD
Cyclophosphamide—Dyspnoea—Niacin—atherosclerosis	0.000228	0.00121	CcSEcCtD
Cyclophosphamide—Paraesthesia—Pravastatin—atherosclerosis	0.000226	0.0012	CcSEcCtD
Cyclophosphamide—Dyspnoea—Pravastatin—atherosclerosis	0.000224	0.00119	CcSEcCtD
Cyclophosphamide—Decreased appetite—Niacin—atherosclerosis	0.000222	0.00118	CcSEcCtD
Cyclophosphamide—Rash—Rosuvastatin—atherosclerosis	0.000221	0.00117	CcSEcCtD
Cyclophosphamide—Dermatitis—Rosuvastatin—atherosclerosis	0.000221	0.00117	CcSEcCtD
Cyclophosphamide—Urticaria—Simvastatin—atherosclerosis	0.000221	0.00117	CcSEcCtD
Cyclophosphamide—Body temperature increased—Simvastatin—atherosclerosis	0.00022	0.00117	CcSEcCtD
Cyclophosphamide—Headache—Rosuvastatin—atherosclerosis	0.00022	0.00117	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000219	0.00116	CcSEcCtD
Cyclophosphamide—Decreased appetite—Pravastatin—atherosclerosis	0.000219	0.00116	CcSEcCtD
Cyclophosphamide—Pain—Niacin—atherosclerosis	0.000218	0.00116	CcSEcCtD
Cyclophosphamide—Fatigue—Pravastatin—atherosclerosis	0.000217	0.00115	CcSEcCtD
Cyclophosphamide—Constipation—Pravastatin—atherosclerosis	0.000215	0.00114	CcSEcCtD
Cyclophosphamide—Pain—Pravastatin—atherosclerosis	0.000215	0.00114	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000215	0.00114	CcSEcCtD
Cyclophosphamide—Asthenia—Lovastatin—atherosclerosis	0.000213	0.00113	CcSEcCtD
Cyclophosphamide—Pruritus—Lovastatin—atherosclerosis	0.00021	0.00112	CcSEcCtD
Cyclophosphamide—Asthenia—Ezetimibe—atherosclerosis	0.000209	0.00111	CcSEcCtD
Cyclophosphamide—Nausea—Rosuvastatin—atherosclerosis	0.000208	0.00111	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000207	0.0011	CcSEcCtD
Cyclophosphamide—Pruritus—Ezetimibe—atherosclerosis	0.000206	0.0011	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Simvastatin—atherosclerosis	0.000205	0.00109	CcSEcCtD
Cyclophosphamide—Diarrhoea—Lovastatin—atherosclerosis	0.000203	0.00108	CcSEcCtD
Cyclophosphamide—Urticaria—Niacin—atherosclerosis	0.000203	0.00108	CcSEcCtD
Cyclophosphamide—Body temperature increased—Niacin—atherosclerosis	0.000202	0.00107	CcSEcCtD
Cyclophosphamide—Urticaria—Pravastatin—atherosclerosis	0.0002	0.00106	CcSEcCtD
Cyclophosphamide—Asthenia—Simvastatin—atherosclerosis	0.0002	0.00106	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ezetimibe—atherosclerosis	0.0002	0.00106	CcSEcCtD
Cyclophosphamide—Body temperature increased—Pravastatin—atherosclerosis	0.000199	0.00106	CcSEcCtD
Cyclophosphamide—Pruritus—Simvastatin—atherosclerosis	0.000197	0.00104	CcSEcCtD
Cyclophosphamide—Dizziness—Lovastatin—atherosclerosis	0.000197	0.00104	CcSEcCtD
Cyclophosphamide—Dizziness—Ezetimibe—atherosclerosis	0.000193	0.00102	CcSEcCtD
Cyclophosphamide—Diarrhoea—Simvastatin—atherosclerosis	0.00019	0.00101	CcSEcCtD
Cyclophosphamide—Vomiting—Lovastatin—atherosclerosis	0.000189	0.001	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Niacin—atherosclerosis	0.000188	0.000999	CcSEcCtD
Cyclophosphamide—Rash—Lovastatin—atherosclerosis	0.000187	0.000995	CcSEcCtD
Cyclophosphamide—Dermatitis—Lovastatin—atherosclerosis	0.000187	0.000994	CcSEcCtD
Cyclophosphamide—Headache—Lovastatin—atherosclerosis	0.000186	0.000989	CcSEcCtD
Cyclophosphamide—Vomiting—Ezetimibe—atherosclerosis	0.000185	0.000984	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Pravastatin—atherosclerosis	0.000185	0.000984	CcSEcCtD
Cyclophosphamide—Dizziness—Simvastatin—atherosclerosis	0.000184	0.000976	CcSEcCtD
Cyclophosphamide—Rash—Ezetimibe—atherosclerosis	0.000184	0.000976	CcSEcCtD
Cyclophosphamide—Dermatitis—Ezetimibe—atherosclerosis	0.000184	0.000975	CcSEcCtD
Cyclophosphamide—Asthenia—Niacin—atherosclerosis	0.000183	0.000973	CcSEcCtD
Cyclophosphamide—Headache—Ezetimibe—atherosclerosis	0.000183	0.00097	CcSEcCtD
Cyclophosphamide—Pruritus—Niacin—atherosclerosis	0.000181	0.000959	CcSEcCtD
Cyclophosphamide—Asthenia—Pravastatin—atherosclerosis	0.00018	0.000958	CcSEcCtD
Cyclophosphamide—Pruritus—Pravastatin—atherosclerosis	0.000178	0.000944	CcSEcCtD
Cyclophosphamide—Vomiting—Simvastatin—atherosclerosis	0.000177	0.000939	CcSEcCtD
Cyclophosphamide—Nausea—Lovastatin—atherosclerosis	0.000177	0.000938	CcSEcCtD
Cyclophosphamide—Rash—Simvastatin—atherosclerosis	0.000175	0.000931	CcSEcCtD
Cyclophosphamide—Dermatitis—Simvastatin—atherosclerosis	0.000175	0.00093	CcSEcCtD
Cyclophosphamide—Diarrhoea—Niacin—atherosclerosis	0.000175	0.000928	CcSEcCtD
Cyclophosphamide—Headache—Simvastatin—atherosclerosis	0.000174	0.000925	CcSEcCtD
Cyclophosphamide—Nausea—Ezetimibe—atherosclerosis	0.000173	0.00092	CcSEcCtD
Cyclophosphamide—Diarrhoea—Pravastatin—atherosclerosis	0.000172	0.000913	CcSEcCtD
Cyclophosphamide—Dizziness—Niacin—atherosclerosis	0.000169	0.000897	CcSEcCtD
Cyclophosphamide—Dizziness—Pravastatin—atherosclerosis	0.000166	0.000883	CcSEcCtD
Cyclophosphamide—Nausea—Simvastatin—atherosclerosis	0.000165	0.000877	CcSEcCtD
Cyclophosphamide—Vomiting—Niacin—atherosclerosis	0.000162	0.000862	CcSEcCtD
Cyclophosphamide—Rash—Niacin—atherosclerosis	0.000161	0.000855	CcSEcCtD
Cyclophosphamide—Dermatitis—Niacin—atherosclerosis	0.000161	0.000854	CcSEcCtD
Cyclophosphamide—Headache—Niacin—atherosclerosis	0.00016	0.000849	CcSEcCtD
Cyclophosphamide—Vomiting—Pravastatin—atherosclerosis	0.00016	0.000849	CcSEcCtD
Cyclophosphamide—Rash—Pravastatin—atherosclerosis	0.000159	0.000842	CcSEcCtD
Cyclophosphamide—Dermatitis—Pravastatin—atherosclerosis	0.000158	0.000841	CcSEcCtD
Cyclophosphamide—Headache—Pravastatin—atherosclerosis	0.000158	0.000836	CcSEcCtD
Cyclophosphamide—Nausea—Niacin—atherosclerosis	0.000152	0.000805	CcSEcCtD
Cyclophosphamide—Nausea—Pravastatin—atherosclerosis	0.000149	0.000793	CcSEcCtD
Cyclophosphamide—CYP2A6—Metabolism—LPL—atherosclerosis	1.03e-05	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.03e-05	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.03e-05	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.03e-05	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.02e-05	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.02e-05	0.00018	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.01e-05	0.00018	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NAMPT—atherosclerosis	1.01e-05	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GPX1—atherosclerosis	1.01e-05	0.000178	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LIPC—atherosclerosis	1.01e-05	0.000178	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOC3—atherosclerosis	1e-05	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CETP—atherosclerosis	9.95e-06	0.000176	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARA—atherosclerosis	9.95e-06	0.000176	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LDLR—atherosclerosis	9.94e-06	0.000176	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CD36—atherosclerosis	9.81e-06	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.75e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—atherosclerosis	9.73e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CETP—atherosclerosis	9.71e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—FABP4—atherosclerosis	9.68e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LCAT—atherosclerosis	9.68e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AGT—atherosclerosis	9.63e-06	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NAMPT—atherosclerosis	9.54e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.53e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SCARB1—atherosclerosis	9.53e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA4—atherosclerosis	9.51e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LIPC—atherosclerosis	9.49e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	9.46e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOE—atherosclerosis	9.44e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOC3—atherosclerosis	9.43e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.41e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LIPC—atherosclerosis	9.4e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LDLR—atherosclerosis	9.37e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAV1—atherosclerosis	9.35e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOC3—atherosclerosis	9.34e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	9.34e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOA1—atherosclerosis	9.33e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SCARB1—atherosclerosis	9.3e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—MTHFR—atherosclerosis	9.29e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LDLR—atherosclerosis	9.29e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.28e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CETP—atherosclerosis	9.15e-06	0.000162	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARA—atherosclerosis	9.12e-06	0.000162	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—atherosclerosis	9.11e-06	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.09e-06	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CETP—atherosclerosis	9.07e-06	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMGCR—atherosclerosis	9e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.98e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—atherosclerosis	8.9e-06	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AGT—atherosclerosis	8.83e-06	0.000156	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMGCR—atherosclerosis	8.78e-06	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.76e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOB—atherosclerosis	8.72e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.69e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOE—atherosclerosis	8.65e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.63e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.61e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAV1—atherosclerosis	8.57e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOA1—atherosclerosis	8.55e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOB—atherosclerosis	8.52e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CG—atherosclerosis	8.52e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—atherosclerosis	8.48e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.46e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—LPL—atherosclerosis	8.33e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—atherosclerosis	8.29e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMGCR—atherosclerosis	8.28e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—atherosclerosis	8.22e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	8.2e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.18e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.18e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.18e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA2—atherosclerosis	8.18e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—LPL—atherosclerosis	8.14e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—atherosclerosis	8.12e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.12e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.08e-06	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—INS—atherosclerosis	8.06e-06	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCA1—atherosclerosis	8.02e-06	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—atherosclerosis	7.94e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CD36—atherosclerosis	7.91e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ABCA1—atherosclerosis	7.83e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CG—atherosclerosis	7.81e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPA—atherosclerosis	7.81e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CD36—atherosclerosis	7.73e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—atherosclerosis	7.71e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BGN—atherosclerosis	7.56e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—atherosclerosis	7.54e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—atherosclerosis	7.5e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA5—atherosclerosis	7.48e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.4e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—atherosclerosis	7.39e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—INS—atherosclerosis	7.39e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOB—atherosclerosis	7.38e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCA1—atherosclerosis	7.38e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARA—atherosclerosis	7.36e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.33e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.31e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.2e-06	0.000128	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARA—atherosclerosis	7.19e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—atherosclerosis	7.18e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AGT—atherosclerosis	7.12e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—atherosclerosis	7.07e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—LPL—atherosclerosis	7.05e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—atherosclerosis	6.98e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AGT—atherosclerosis	6.96e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.96e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAV1—atherosclerosis	6.92e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOA1—atherosclerosis	6.9e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.88e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—atherosclerosis	6.88e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—atherosclerosis	6.82e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—atherosclerosis	6.78e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAV1—atherosclerosis	6.76e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOA1—atherosclerosis	6.74e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—atherosclerosis	6.72e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CD36—atherosclerosis	6.7e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOB—atherosclerosis	6.59e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—atherosclerosis	6.48e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—atherosclerosis	6.47e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOB—atherosclerosis	6.43e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.41e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—atherosclerosis	6.35e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.33e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CG—atherosclerosis	6.3e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LPL—atherosclerosis	6.29e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.27e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—atherosclerosis	6.26e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.24e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARA—atherosclerosis	6.23e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LIPC—atherosclerosis	6.2e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOC3—atherosclerosis	6.16e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.16e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LPL—atherosclerosis	6.14e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—atherosclerosis	6.14e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LDLR—atherosclerosis	6.13e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—atherosclerosis	6.08e-06	0.000108	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOB—atherosclerosis	6.06e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AGT—atherosclerosis	6.03e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOB—atherosclerosis	6.01e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—atherosclerosis	5.99e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CETP—atherosclerosis	5.98e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CD36—atherosclerosis	5.98e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—INS—atherosclerosis	5.96e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—atherosclerosis	5.94e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—atherosclerosis	5.93e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—atherosclerosis	5.91e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.9e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAV1—atherosclerosis	5.86e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.85e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOA1—atherosclerosis	5.84e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CD36—atherosclerosis	5.84e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—INS—atherosclerosis	5.83e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LPL—atherosclerosis	5.79e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LPL—atherosclerosis	5.74e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.73e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.67e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—atherosclerosis	5.65e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—atherosclerosis	5.6e-06	9.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARA—atherosclerosis	5.56e-06	9.85e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—atherosclerosis	5.53e-06	9.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CD36—atherosclerosis	5.5e-06	9.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—atherosclerosis	5.47e-06	9.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CD36—atherosclerosis	5.45e-06	9.66e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARA—atherosclerosis	5.43e-06	9.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.41e-06	9.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AGT—atherosclerosis	5.38e-06	9.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—atherosclerosis	5.34e-06	9.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.33e-06	9.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—atherosclerosis	5.28e-06	9.35e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AGT—atherosclerosis	5.25e-06	9.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—atherosclerosis	5.23e-06	9.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAV1—atherosclerosis	5.23e-06	9.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOA1—atherosclerosis	5.21e-06	9.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.21e-06	9.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.17e-06	9.15e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—atherosclerosis	5.15e-06	9.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—atherosclerosis	5.15e-06	9.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARA—atherosclerosis	5.11e-06	9.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—atherosclerosis	5.11e-06	9.06e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAV1—atherosclerosis	5.1e-06	9.04e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOA1—atherosclerosis	5.09e-06	9.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARA—atherosclerosis	5.07e-06	8.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—INS—atherosclerosis	5.05e-06	8.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AGT—atherosclerosis	4.95e-06	8.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AGT—atherosclerosis	4.91e-06	8.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—atherosclerosis	4.89e-06	8.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—atherosclerosis	4.85e-06	8.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.82e-06	8.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—atherosclerosis	4.81e-06	8.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAV1—atherosclerosis	4.81e-06	8.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOA1—atherosclerosis	4.8e-06	8.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—atherosclerosis	4.78e-06	8.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAV1—atherosclerosis	4.77e-06	8.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.76e-06	8.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOA1—atherosclerosis	4.75e-06	8.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.68e-06	8.28e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.65e-06	8.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—atherosclerosis	4.63e-06	8.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—atherosclerosis	4.59e-06	8.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—INS—atherosclerosis	4.51e-06	7.98e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—atherosclerosis	4.48e-06	7.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—atherosclerosis	4.43e-06	7.85e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—INS—atherosclerosis	4.4e-06	7.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.38e-06	7.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.34e-06	7.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—atherosclerosis	4.23e-06	7.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—atherosclerosis	4.19e-06	7.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—INS—atherosclerosis	4.14e-06	7.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.14e-06	7.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—atherosclerosis	4.13e-06	7.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—INS—atherosclerosis	4.11e-06	7.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.05e-06	7.18e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—atherosclerosis	4.03e-06	7.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOB—atherosclerosis	3.96e-06	7.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—atherosclerosis	3.95e-06	7e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—atherosclerosis	3.86e-06	6.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.86e-06	6.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—atherosclerosis	3.8e-06	6.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPL—atherosclerosis	3.78e-06	6.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—atherosclerosis	3.77e-06	6.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—atherosclerosis	3.69e-06	6.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—atherosclerosis	3.63e-06	6.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.61e-06	6.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—atherosclerosis	3.6e-06	6.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CD36—atherosclerosis	3.6e-06	6.37e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—atherosclerosis	3.53e-06	6.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.41e-06	6.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARA—atherosclerosis	3.34e-06	5.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.32e-06	5.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.3e-06	5.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—atherosclerosis	3.25e-06	5.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AGT—atherosclerosis	3.24e-06	5.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—atherosclerosis	3.17e-06	5.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAV1—atherosclerosis	3.14e-06	5.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA1—atherosclerosis	3.14e-06	5.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—atherosclerosis	2.98e-06	5.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.86e-06	5.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—atherosclerosis	2.76e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—INS—atherosclerosis	2.71e-06	4.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—atherosclerosis	2.48e-06	4.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—atherosclerosis	2.4e-06	4.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—atherosclerosis	2.38e-06	4.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—atherosclerosis	2.35e-06	4.16e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.17e-06	3.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—atherosclerosis	2.04e-06	3.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—atherosclerosis	1.82e-06	3.22e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—atherosclerosis	1.77e-06	3.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—atherosclerosis	1.67e-06	2.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—atherosclerosis	1.66e-06	2.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.09e-06	1.94e-05	CbGpPWpGaD
